000028064 000__ 01519cam\a22003255i\4500
000028064 000__ 01574nam\a2200349Ia\4500
000028064 001__ 28064
000028064 003__ SzGeWIPO
000028064 005__ 20230120174702.0
000028064 008__ 171027s2017\\\\nyr\\\\\rb\\\\000\|\eng\d|\eng\d
000028064 035__ $$a(OCoLC)1160577885
000028064 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000028064 1102_ $$aWorld Intellectual Property Organization
000028064 24510 $$aAntimicrobial Resistance (AMR) and Multidrug Resistance (MDR): Overview of current approaches, consortia and intellectual property issues :$$bGlobal Challenges Report.
000028064 264_1 $$a[Geneva, Switzerland] :$$b[World Intellectual Property Organization],$$c2017.
000028064 300__ $$a[English] ;$$c[28] cm.
000028064 336__ $$atext$$btxt$$2rdacontent
000028064 337__ $$aunmediated$$bn$$2rdamedia
000028064 338__ $$avolume$$bnc$$2rdacarrier
000028064 4901_ $$aWIPO Publication
000028064 5050_ $$aBased on a review of recent literature, this WIPO Global Challenges Report includes a broad overview of current approaches and consortia designed to meet the challenge of research and development (R&D) investment for new treatments. It also examines patent applications by both the public and the private sectors as an indicator of innovative activity.
000028064 542__ $$fLicense: CC BY 3.0 IGO
000028064 650_0 $$aPatents.
000028064 650_0 $$aIntellectual property.
000028064 650_4 $$aGlobal Health
000028064 7001_ $$aBhagwandi, Niresh.
000028064 830_0 $$aWIPO Publication.
000028064 8564_ $$uhttp://www.wipo.int/edocs/pubdocs/en/wipo_pub_gc_15.pdf$$yView electronic version
000028064 903__ $$aWIPO Publication
000028064 942__ $$cMON$$2ddc
000028064 980__ $$aBIB
000028064 999__ $$c31120$$d31120